Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market growth can be hindered by high cost of chemotherapy-induced nausea and vomiting (cinv) treatment drugs. For instance, according to GoodRx, Inc., a healthcare company that operates a telemedicine platform and a free-to-use website and mobile app that track prescription drug prices in the U.S., the average retail price of 1 capsule Akynzeo (Netupitant and Palonosetron Capsules) is around US$ 570.8.
Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market : Restraint
Poor Reimbursement Policies
Poor reimbursement policies and healthcare financing structures in low economies such as Middle East is expected to act as a restraint for the market growth over the forecast period. For instance, according to an article published by the European Medical Journal, in August 2020, antiemetic guidelines are valid in countries where drugs are available and reimbursed; however, this is not the case in some parts of the world.
Cancer Chemotherapy Associated Nausea And Vomiting Therapeutics Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients